The infinite possibilities of RNA therapeutics.

Journal of Industrial Microbiology & Biotechnology
Evelyn C Mollocana-LaraFernando A Gonzales-Zubiate


Although the study of RNA therapeutics started decades ago, for many years, this field of research was overshadowed by the growing interest in DNA-based therapies. Nowadays, the role of several types of RNA in cell regulation processes and the development of various diseases have been elucidated, and research in RNA therapeutics is back with force. This short literature review aims to present general aspects of many of the molecules currently used in RNA therapeutics, including in vitro transcribed mRNA, antisense oligonucleotides, aptamers, small interfering RNAs, and microRNAs. In addition, we describe the state of the art of technologies applied for synthetic RNA manufacture and delivery. Likewise, we detail the RNA-based therapies approved by the FDA so far, as well as the ongoing clinical investigations. As a final point, we highlight the current and potential advantages of working on RNA-based therapeutics and how these could lead us to a new era of accessible and personalized healthcare.


Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Mar 23, 1990·Science·J A WolffP L Felgner
Aug 30, 1990·Nature·A D Ellington, J W Szostak
Jun 1, 1991·Analytical Biochemistry·V V GurevichS A Zozulya
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R W MaloneI M Verma
Jan 1, 1987·Methods in Enzymology·P A Krieg, D A Melton
Aug 8, 1970·Nature·F Crick
Oct 6, 2001·Methods in Enzymology·F Houser-ScottD R Engelke
Jul 9, 2002·Biochemical and Biophysical Research Communications·Marianne Leirdal, Mouldy Sioud
Aug 31, 2002·Angewandte Chemie·Ronald Micura
Aug 19, 2003·RNA·Jacek JemielityRobert E Rhoads
Jan 23, 2004·PLoS Biology·Richard Robinson
Mar 16, 2004·Methods in Molecular Biology·Mouldy Sioud, Marianne Leirdal
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gary K KoskiBrian J Czerniecki
Jun 9, 2004·Current Opinion in Chemical Biology·William S Marshall, Robert J Kaiser
Dec 27, 2006·Cell Research·Allison N Martin, Yong Li
Sep 18, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katalin KarikóDrew Weissman
Feb 26, 2009·Cell·Jonathan Houseley, David Tollervey
Oct 14, 2009·Drug Discovery Today·Reema RoshanBeena Pillai
Jul 14, 2010·Biochimica Et Biophysica Acta·Fazli WahidYou Young Kim
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Larry GoldDom Zichi
Aug 4, 2011·British Journal of Haematology·Sarah ShigdarWei Duan
Jan 11, 2012·Silence·Jan StenvangSakari Kauppinen
Jan 31, 2012·Chemistry & Biology·John C Burnett, John J Rossi
Jun 26, 2012·Trends in Biochemical Sciences·J Arturo Londoño-Vallejo, Raymund J Wellinger
Mar 27, 2013·International Journal of Molecular Sciences·Guodong FuChun Peng
Apr 9, 2013·Drugs·Philip HairKate McKeage
Jun 26, 2013·Future Medicinal Chemistry·Marcin ZiemniakJacek Jemielity
Sep 17, 2013·Molecular Cell·Yang ZhangLing-Ling Chen
Mar 29, 2014·Expert Opinion on Drug Delivery·Raquel P DeeringAndrew J Geall
May 9, 2014·Nature Biotechnology·William R Jeck, Norman E Sharpless
Sep 23, 2014·Nature Reviews. Drug Discovery·Ugur SahinÖzlem Türeci
Sep 16, 2015·Molecular Therapy. Nucleic Acids·Jenny K W LamSusan W S Leung
Nov 28, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qinchang ZhuMasaaki Kai
Apr 20, 2016·Molecular Therapy. Nucleic Acids·Alexandra E GrierKyle Jacoby
May 24, 2016·Nature Materials·R MolinaroE Tasciotti
Jun 12, 2016·Nucleic Acids Research·Mallory A Havens, Michelle L Hastings
Nov 4, 2016·Drugs·Yahiya Y Syed
Dec 28, 2016·Database : the Journal of Biological Databases and Curation·Allison PiovesanLorenza Vitale
Feb 24, 2017·Drugs·Sheridan M Hoy
Mar 1, 2017·Nature Biotechnology·Anastasia Khvorova, Jonathan K Watts
Apr 4, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cy A Stein, Daniela Castanotto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Frontiers in Bioengineering and Biotechnology
Tulsi Ram DamaseJohn P Cooke
Current Opinion in Cardiology
Christian BoadaJohn P Cooke
© 2021 Meta ULC. All rights reserved